Design and discovery of neuropeptide Y1 receptor antagonists
- 31 January 1997
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 2 (1) , 19-24
- https://doi.org/10.1016/s1359-6446(96)10049-0
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Esophageal dilation in the sitting, sedated patient is safe and effectiveGastrointestinal Endoscopy, 1996
- Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor familyFEBS Letters, 1996
- Endogenous NPY acting on the Y1 receptor accounts for the long‐lasting part of the sympathetic contraction in guinea‐pig cava: evidence using SR 120107AActa Physiologica Scandinavica, 1995
- Review: Cardiovascular & Renal Nouropeptide Y: a promising therapeutic targetExpert Opinion on Therapeutic Patents, 1995
- SR120819A, an orally‐active and selective neuropeptide Y Y1 receptor antagonistFEBS Letters, 1995
- Is PP56 (D-myo-inositol-1, 2, 6-triphosphate) an antagonist at neuropeptide Y receptors?Life Sciences, 1993
- Solution conformation of human neuropeptide Y by 1H nuclear magnetic resonance and restrained molecular dynamicsEuropean Journal of Biochemistry, 1992
- Structure of neuropeptide Y dimer in solutionEuropean Journal of Biochemistry, 1992
- Signal Epitopes in the Three‐Dimensional Structure of Neuropeptide YAnnals of the New York Academy of Sciences, 1990
- Highly potent and small neuropeptide Y agonist obtained by linking NPY 1–4 via spacer to α‐helical NPY 25–36FEBS Letters, 1989